Health and Healthcare Systems
Nature and AI in drug discovery: a solution to high costs
Here's how AI & nature revolutionize drug development, tackling high costs and clinical trial failures to make affordable medicines a reality. Learn more.
Viswa Colluru
Viswa is the CEO and Founder of Enveda, which he has scaled to a clinical-stage company fueled by 250 employees and >$300M in capital in just over 5 years. He brings over a decade of experience in translational biomedical discovery across commercial strategy and research. He previously served as the first Innovation Scientist and Product Manager at Recursion, where he also established the Portfolio/Early Commercial team. Viswa holds the distinction of being the youngest PhD graduate from UW Madison’s CMB Class of 2011, where he developed novel candidate immunotherapies. Viswa was named a UBS Global Visionary in 2023. In his spare time, Viswa enjoys playing and watching racquet sports of all kinds, trying to read several books in parallel, and traveling with his wife Haliee.
Most Popular